Capron Dmt Tablet
Product Images NDC 29978-128

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Capron Dmt (NDC 29978-128). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Capital Pharma, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Pdp (Pdp)

Capron DMT Tablets label shows an antitussive and antihistamine oral tablet containing 30 mg each of Dextromethorphan HBr and Pyrilamine Maleate. The label includes the Capital Pharma logo and states a package size of 100 tablets. It also warns that the product is tamper-evident with a foil seal under the cap, and advises not to use if the seal is broken or missing. Manufacturer information for Capital Pharma, Powell, OH 43065, is included.*

FDA Label Image

Drug Facts (Drug Facts)

Drug Facts text panels for Capron DMT tablets containing Dextromethorphan HBr 30 mg and Pyrilamine Maleate 30 mg. The panels include active ingredients and their purposes, uses for common cold and allergies, directions for dosage, storage instructions, warnings including contraindications and precautions, and guidance on when to ask a doctor before use or in case of pregnancy or breastfeeding.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.